Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Baas

Showing results (221-230 of 245) with videos related to

Pageof 25
Sort By:
Circulation. Genomic and Precision Medicine|December 17, 2024
Recreational and Occupational Physical Activity and Risk of Adverse Events in Truncating <i>MYBPC3</i> Founder Variant CarriersFahima Hassanzada, Mark Jansen, Freyja H M van Lint, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 15, 2023
The genetic basis of apparently idiopathic ventricular fibrillation: a retrospective overviewLisa M Verheul, Martijn H van der Ree, Sanne A Groeneveld, et al.
International Journal of Cardiology|July 10, 2021
A novel risk model for predicting potentially life-threatening arrhythmias in non-ischemic dilated cardiomyopathy (DCM-SVA risk)Elham Kayvanpour, Arjan Sammani, Farbod Sedaghat-Hamedani, et al.
JAMA Cardiology|December 1, 2017
Genetic Association of Lipids and Lipid Drug Targets With Abdominal Aortic Aneurysm: A Meta-analysisSeamus C Harrison, Michael V Holmes, Stephen Burgess, et al.
Circulation. Genomic and Precision Medicine|September 30, 2022
Genetic Evaluation of A Nation-Wide Dutch Pediatric DCM Cohort: The Use of Genetic Testing in Risk StratificationMarijke H van der Meulen, Johanna C Herkert, Susanna L den Boer, et al.
Clinical Epigenetics|March 24, 2021
Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutationsJ Pei, M Schuldt, E Nagyova, et al.
European Heart Journal|November 1, 2012
Interleukin-6 receptor pathways in abdominal aortic aneurysmSeamus C Harrison, Andrew J P Smith, Gregory T Jones, et al.
Circulation. Genomic and Precision Medicine|August 29, 2019
Biallelic Variants in <i>ASNA1</i>, Encoding a Cytosolic Targeting Factor of Tail-Anchored Proteins, Cause Rapidly Progressive Pediatric CardiomyopathyJudith M A Verhagen, Myrthe van den Born, Herma C van der Linde, et al.
Circulation. Genomic and Precision Medicine|May 22, 2019
Mortality Risk Associated With Truncating Founder Mutations in TitinMark Jansen, Annette F Baas, Karin Y van Spaendonck-Zwarts, et al.
Journal of the American College of Cardiology|February 16, 2018
Genetics, Clinical Features, and Long-Term Outcome of Noncompaction CardiomyopathyJaap I van Waning, Kadir Caliskan, Yvonne M Hoedemaekers, et al.
Pageof 25

Showing results (221-230 of 245) with videos related to

Sort By:
Pageof 25
Circulation. Genomic and Precision Medicine|December 17, 2024
Recreational and Occupational Physical Activity and Risk of Adverse Events in Truncating <i>MYBPC3</i> Founder Variant CarriersFahima Hassanzada, Mark Jansen, Freyja H M van Lint, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 15, 2023
The genetic basis of apparently idiopathic ventricular fibrillation: a retrospective overviewLisa M Verheul, Martijn H van der Ree, Sanne A Groeneveld, et al.
International Journal of Cardiology|July 10, 2021
A novel risk model for predicting potentially life-threatening arrhythmias in non-ischemic dilated cardiomyopathy (DCM-SVA risk)Elham Kayvanpour, Arjan Sammani, Farbod Sedaghat-Hamedani, et al.
JAMA Cardiology|December 1, 2017
Genetic Association of Lipids and Lipid Drug Targets With Abdominal Aortic Aneurysm: A Meta-analysisSeamus C Harrison, Michael V Holmes, Stephen Burgess, et al.
Circulation. Genomic and Precision Medicine|September 30, 2022
Genetic Evaluation of A Nation-Wide Dutch Pediatric DCM Cohort: The Use of Genetic Testing in Risk StratificationMarijke H van der Meulen, Johanna C Herkert, Susanna L den Boer, et al.
Clinical Epigenetics|March 24, 2021
Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutationsJ Pei, M Schuldt, E Nagyova, et al.
European Heart Journal|November 1, 2012
Interleukin-6 receptor pathways in abdominal aortic aneurysmSeamus C Harrison, Andrew J P Smith, Gregory T Jones, et al.
Circulation. Genomic and Precision Medicine|August 29, 2019
Biallelic Variants in <i>ASNA1</i>, Encoding a Cytosolic Targeting Factor of Tail-Anchored Proteins, Cause Rapidly Progressive Pediatric CardiomyopathyJudith M A Verhagen, Myrthe van den Born, Herma C van der Linde, et al.
Circulation. Genomic and Precision Medicine|May 22, 2019
Mortality Risk Associated With Truncating Founder Mutations in TitinMark Jansen, Annette F Baas, Karin Y van Spaendonck-Zwarts, et al.
Journal of the American College of Cardiology|February 16, 2018
Genetics, Clinical Features, and Long-Term Outcome of Noncompaction CardiomyopathyJaap I van Waning, Kadir Caliskan, Yvonne M Hoedemaekers, et al.
Pageof 25